Grants to USA medical, nursing, and pharmacy schools, healthcare institutions, medical education companies, professional associations and societies, and other entities in the field of women's health for projects on endometriosis or uterine fibroids. Funding is intended to improve care for women with the aforementioned conditions.
Projects that will be considered for support will focus on improving the care of patients by addressing knowledge gaps in following areas:
Uterine Fibroids
Review recent clinical management guidelines for management of uterine fibroids, current treatment options (e.g., surgery and medical) and highlight gaps in care/management
Review treatment goals, patient preferences (e.g., to preserve fertility/uterus or avoid invasive procedures), and the need for shared decision making
Highlight the burden of uterine fibroids symptoms (e.g., heavy menstrual bleeding, bulk symptoms, pain, negative effects on quality of life, psychosocial wellbeing, etc.) and available management options
Educate on the estrogen threshold hypothesis and the role of GnRH antagonists as a treatment for uterine fibroids, including recent long-term treatment data
Endometriosis
Educate on how the use of imaging, patient history, and physical examination may facilitate an earlier clinical diagnosis of endometriosis and how these may be used to shift away from surgical diagnosis
Inform how delays in diagnosis can contribute to increased patient distress (including negative effects on quality of life, psychosocial wellbeing, etc.) and what long-term impact this may have on prognosis and treatment (i.e.: centralization of pain)
Review the use of medical therapies early in the treatment journey and in conjunction with surgery, and how this may affect the need for repeated surgery
Highlight the estrogen threshold hypothesis and the role of GnRH antagonists as a treatment for endometriosis, with emphasis on long-term efficacy & safety results.
The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement in women’s health.
If the project involves multiple departments within an institution and/or between different institutions/organizations/associations, all institutions must have a relevant role and the requesting organization must have a key role in the project.
For projects offering continuing education credit, the requesting organization must be accredited.
Ineligible
It is not Pfizer's intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.
Pre-Application Information
Timeline:
• RFP release date: December 5, 2022
• Grant Application due date: February 15, 2023
Please note the deadline is 23:59 Eastern Standard Time
• Anticipated Grant Award Notification Date: April 2023
• Grants will be distributed following a fully executed agreement.
Additional Funding Information
Estimated Total Program Funding:
$750,000
Estimated Size of Grant
Individual projects requesting up to $200,000 will be considered.
Term of Contract
Anticipated Approx. Project Start: May 2023 (1 year to 18 months project length is preferred; maximum project length is 2 years)
